Keyword Analysis & Research: antimicrobial resistance in eskape pathogens

hindawi.com

https://www.hindawi.com/journals/bmri/2016/2475067/

2.1. Drug Inactivation or Alteration

DA: 72 PA: 78 MOZ Rank: 19

nih.gov

https://pubmed.ncbi.nlm.nih.gov/32404435/

May 13, 2020 · Antimicrobial-resistant ESKAPE ( E nterococcus faecium, S taphylococcus aureus, K lebsiella pneumoniae, A cinetobacter baumannii, P seudomonas aeruginosa, and E nterobacter species) pathogens represent a global threat to human health. The acquisition of antimicrobial resistance genes by ESKAPE pathogens has reduced the treatment options … Author: David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, Patrick N. A. Harris, Mark A. Schembri, Sc... Publish Year: 2020

Author: David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, Patrick N. A. Harris, Mark A. Schembri, Sc...

Publish Year: 2020

DA: 11 PA: 52 MOZ Rank: 59

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227449/

May 13, 2020 · Mechanisms facilitating antimicrobial resistance in ESKAPE pathogens can be broadly categorized into four groups: (i) enzyme-mediated antimicrobial inactivation, which either irreversibly destroys the active antibiotic site (e.g., hydrolytic cleavage of the β-lactam ring by β-lactamases) or covalently modifies key structural elements of the drug to hinder the bacterial … Author: David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, Patrick N. A. Harris, Mark A. Schembri, Sc... Publish Year: 2020

Author: David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, Patrick N. A. Harris, Mark A. Schembri, Sc...

Publish Year: 2020

DA: 20 PA: 65 MOZ Rank: 82

nih.gov

https://pubmed.ncbi.nlm.nih.gov/27274985/

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are the leading cause of nosocomial infections throughout the world. Most of them are multidrug resistant isolates, … Author: Sirijan Santajit, Nitaya Indrawattana Publish Year: 2016

Author: Sirijan Santajit, Nitaya Indrawattana

Publish Year: 2016

DA: 89 PA: 38 MOZ Rank: 73

asm.org

https://journals.asm.org/doi/abs/10.1128/cmr.00181-19?etoc=

The acquisition of antimicrobial resistance genes by ESKAPE pathogens has reduced the treatment options for serious infections, increased the burden of disease, and increased death rates due to treatment failure and requires a coordinated global response for antimicrobial resistance surveillance.

DA: 52 PA: 34 MOZ Rank: 1

hindawi.com

https://www.hindawi.com/journals/bmri/2016/2475067/

Antimicrobial resistance genes may be carried on the bacterial chromosome, plasmid, or transposons [6]. Mechanisms of drug resistance fall into several broad categories, including drug inactivation/alteration, modification of drug binding sites/targets, changes in cell permeability resulting in reduced intracellular drug accumulation, and biofilm f... Author: Sirijan Santajit, Nitaya Indrawattana Publish Year: 2016

Antimicrobial resistance genes may be carried on the bacterial chromosome, plasmid, or transposons [6]. Mechanisms of drug resistance fall into several broad categories, including drug inactivation/alteration, modification of drug binding sites/targets, changes in cell permeability resulting in reduced intracellular drug accumulation, and biofilm f...

Author: Sirijan Santajit, Nitaya Indrawattana

Publish Year: 2016

DA: 49 PA: 84 MOZ Rank: 68

antimicrobianos.com.ar

http://antimicrobianos.com.ar/ATB/wp-content/uploads/2020/11/Antimicrobial-Resistance-in-ESKAPE-Pathogens.pdf

Of these 11 antimicrobials,4wereapprovedbytheEuropeanUnionEuropeanMedicinesAgency (E.U. EMA): the meropenem-vaborbactam combination (Vaborem), eravacycline (Xe- rava),delafloxacin(Baxdela/Quofenix),andtheimipenem-cilastatin-relebactamcombi- nation(Recarbrio;apositiveopiniontowardthegrantingofmarketingauthorization DeOliveiraetal.

DA: 12 PA: 66 MOZ Rank: 99

iapc-obp.com

http://iapc-obp.com/assets/files/562657_15_FAR_1.pdf

Antimicrobial resistance (AMR) is the ability of a microorganism to withstand antimicrobial compounds. The evolution of AMR is a natural phenomenon that results from bacterial gene mutations or the acquisition of exogenous resistance genes present in mobile genetic elements that are able to propagate horizontally between bacteria. The use of antimicrobial agents …

DA: 62 PA: 74 MOZ Rank: 56

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452778/

12 rows · Apr 01, 2019 · The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance and ...

DA: 83 PA: 28 MOZ Rank: 86

mdpi.com

https://www.mdpi.com/journal/antibiotics/special_issues/ESKAPE_Pathogen

May 12, 2022 · The ESKAPE acronym describes the pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) that are the leading cause of nosocomial infections throughout the world, representing paradigms of antimicrobial resistance, pathogenesis …

DA: 71 PA: 9 MOZ Rank: 39

cdc.gov

https://www.cdc.gov/drugresistance/biggest-threats.html

Erythromycin-resistant Group A Streptococcus (GAS) GAS bacteria can cause many different infections that range from minor illnesses to serious and deadly diseases, including strep throat, pneumonia, flesh-eating infections, and sepsis. 5,400 estimated drug-resistant infections in 2017. 450 estimated deaths in 2017.

DA: 47 PA: 91 MOZ Rank: 2